中药配合血液透析治疗尿毒症的临床研究

目的：进一步提高尿毒症终末期维持血透患者的透析效果及生活质量。方法：采用中成药通脉口服液。大黄胶囊口服配合血液透析治疗尿毒症终末期患者３０例，并设对照组３０例，仅予常规血液透析。两组疗程的１个月，连续观察３个月。结果：治疗组３０例中所测得的平均时间尿毒氮浓度（ＴＡＣｕｒｅａ）蛋白质分解率（ＰＣＲ）及Ｇ－Ｓ指数（ＫＴ／Ｖ值），均明显优于对照组（Ｐ〈０．０５）。结论；通脉口服液、大黄胶囊配合血液透析在

Clinical Study on Effect of Chinese Herbal Medicine Combined with Hemodialysis in Treating Uremia

Objective: To elevate the efficacy of dialysis in uremia patients treated with maintaining hemodialysis. Methods: Thirty patients of terminal stage uremia were treated with Tongmai oral liquid and rhubarb capsule combined with hemodialysis were observed and compared with a control group of 30 patients treated with hemodialysis alone. The therapeutic course of both groups was 1 month and the observation lasted for 3 months consecutively. Results: The mean time urea nitrogen concentration, protein catabdic rate and the GS index (KT/V value) of the treated group were all better than those of the control group (P<0 05). Conclusion: Uremia patients treated with Tongmai oral liquid and rhubarb capsule combined with hemodialysis were better in full utilization of hemodialysis and life quality of patients in comparison with patients treated with hemodialysis alone.